These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 6410450)

  • 21. Evaluation of visual function in healthy subjects after administration of Ro 15-1788.
    Lupolover Y; Safran AB; Desangles D; de Weisse C; Meyer JJ; Bousquet A; Assimacopoulos A
    Eur J Clin Pharmacol; 1984; 27(4):505-7. PubMed ID: 6440793
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intrinsic actions of the benzodiazepine receptor antagonist Ro 15-1788.
    File SE; Pellow S
    Psychopharmacology (Berl); 1986; 88(1):1-11. PubMed ID: 3003778
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A behavioral examination of convulsant benzodiazepine and GABA antagonist, Ro 5-3663, and benzodiazepine-receptor antagonist Ro 15-1788.
    Feldon J; Lerner T; Levin D; Myslobodsky M
    Pharmacol Biochem Behav; 1983 Jul; 19(1):39-41. PubMed ID: 6413985
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationship of the effects of the benzodiazepine derivative clorazepate on corticosterone secretion with its behavioural actions. Antagonism by Ro 15-1788.
    Mormede P; Dantzer R; Perio A
    Pharmacol Biochem Behav; 1984 Dec; 21(6):839-43. PubMed ID: 6151666
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential effects of the benzodiazepine antagonist Ro 15-1788 after "general anaesthetic" doses of benzodiazepines in mice.
    Little HJ; Bichard AR
    Br J Anaesth; 1984 Oct; 56(10):1153-60. PubMed ID: 6148095
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of the benzodiazepine antagonist, flumazenil, on psychometric performance in acute ethanol intoxication in man.
    Clausen TG; Wolff J; Carl P; Theilgaard A
    Eur J Clin Pharmacol; 1990; 38(3):233-6. PubMed ID: 2111244
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Action of the benzodiazepine antagonist Ro 15-1788 in humans after sleep withdrawal.
    Emrich HM; Sonderegger P; Mai N
    Neurosci Lett; 1984 Jun; 47(3):369-73. PubMed ID: 6433243
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Behavioral effects and benzodiazepine antagonist activity of Ro 15-1788 (flumazepil) in pigeons.
    Witkin JM; Barrett JE
    Life Sci; 1985 Oct; 37(17):1587-95. PubMed ID: 2932617
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early clinical pharmacological trials with a novel partial benzodiazepine agonist/antagonist Ro 17-1812 using pharmaco-EEG and psychometry.
    Saletu B; Grünberger J; Linzmayer L
    Methods Find Exp Clin Pharmacol; 1986 Jun; 8(6):373-89. PubMed ID: 3736281
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Electrophysiological aspects of benzodiazepine antagonists, Ro 15-1788 and Ro 15-3505.
    Gath I; Weidenfeld J; Collins GI; Hadad H
    Br J Clin Pharmacol; 1984 Oct; 18(4):541-7. PubMed ID: 6435655
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Benzodiazepine antagonist Ro 15-1788 counteracts the prolactin-lowering effects of other benzodiazepines in rats.
    Lotz W
    Neuroendocrinology; 1982; 35(1):32-6. PubMed ID: 6287328
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The partial benzodiazepine agonist properties of Ro 15-1788 in pentylenetetrazol-induced seizures in cats.
    Kaijima M; Le Gal La Salle G; Rossier J
    Eur J Pharmacol; 1983 Sep; 93(1-2):113-5. PubMed ID: 6414826
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Convulsions induced by submaximal dose of pentylenetetrazol in mice are antagonized by the benzodiazepine antagonist Ro 15-1788.
    Grecksch G; de Carvalho LP; Venault P; Chapouthier G; Rossier J
    Life Sci; 1983 May; 32(22):2579-84. PubMed ID: 6406779
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Convulsant effect of Ro 5-4864, a peripheral type benzodiazepine, on the baboon (Papio papio).
    Valin A; Bryere P; Naquet R
    Neurosci Lett; 1986 May; 66(2):210-4. PubMed ID: 3014388
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The benzodiazepine antagonist, Ro 15-1788 does not decrease ethanol withdrawal convulsions in rats.
    Little HJ; Taylor SC; Nutt DJ; Cowen PJ
    Eur J Pharmacol; 1985 Jan; 107(3):375-7. PubMed ID: 3920059
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The action of benzodiazepine antagonist Ro 15-1788 on the effects of GABA-ergic drugs.
    Allikmets LH; Rägo LK
    Naunyn Schmiedebergs Arch Pharmacol; 1983 Nov; 324(3):235-7. PubMed ID: 6318128
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reversal of antinociceptive effect of cholecystokinin by benzodiazepines and a benzodiazepine antagonist, Ro 15-1788.
    Kubota K; Sugaya K; Matsuda I; Matsuoka Y; Terawaki Y
    Jpn J Pharmacol; 1985 Jan; 37(1):101-5. PubMed ID: 2859382
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of hypothermic effect of cholecystokinin by benzodiazepines and a benzodiazepine antagonist, Ro 15-1788, in mice.
    Sugaya K; Matsuda I; Kubota K
    Jpn J Pharmacol; 1985 Oct; 39(2):277-80. PubMed ID: 2868143
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recovery from lorazepam tolerance and the effects of a benzodiazepine antagonist (RO 15-1788) on the development of tolerance.
    File SE
    Psychopharmacology (Berl); 1982; 77(3):284-8. PubMed ID: 6126909
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Investigation in man of the efficacy of a benzodiazepine antagonist, Ro 15-1788.
    Darragh A; Lambe R; Scully M; Brick I; O'Boyle C; Downe WW
    Lancet; 1981 Jul; 2(8236):8-10. PubMed ID: 6113428
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.